By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



13859 Progress Boulevard
Suite 300
Alachua  Florida  32615  U.S.A.
Phone: 386-462-9663 Fax: 386-462-2087



Company News
Trethera And Nanotherapeutics Sign Exclusive Worldwide Agreement For Rights To Triapine In Hematological Malignancies 1/5/2017 8:43:58 AM
Nanotherapeutics Appoints Prasad Raje, Ph.D. As President And Chief Executive Officer 12/1/2016 8:13:19 AM
Nanotherapeutics Receives NIAID Contract As Part Of A Multiple Award Pool For Task Orders Valued At Up To $159.4 Million 9/20/2016 11:23:33 AM
Former Bill & Melinda Gates Foundation And Baxter International (BAX) Executive Peter H. Khoury, Ph.D. Joins Nanotherapeutics As Chief Commercial Officer 8/3/2016 11:07:05 AM
Nanotherapeutics Closes Sale-Leaseback Financing With Senior Housing Properties Trust For The Company’s New Advanced Development And Manufacturing Facility In Alachua, FL 5/6/2016 9:52:25 AM
Nanotherapeutics Grants Worldwide Rights To Amend Surgical For Nanofuse DBM 1/6/2016 10:49:32 AM
Struggling XOMA  (XOMA) Sells Biologics Manufacturing Facilities to Agenus (AGEN), Divests Biodefense Program to Nanotherapeutics 11/6/2015 5:55:05 AM
Takeda (TKPYY) And Nanotherapeutics Announce Agreement To Expand Takeda's Commercialization And Technology Access Rights In Support Of Influenza And Other Vaccine Programs 8/27/2015 10:44:37 AM
Nanotherapeutics Awarded Biomedical Advanced Research and Development Authority (BARDA) Fill-Finish Manufacturing Network Task Orders To Develop Two FDA Drug Shortage Products 7/10/2015 9:49:44 AM
Nanotherapeutics Receives Expanded 510(K) Marketing Clearance From The FDA For Nanofuse DBM 2/10/2015 11:39:25 AM